newsfilter
← Latest News
GlobeNewswire·

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic